Long-Term Outcomes of Consolidative Proton Therapy for Pediatric Classical Hodgkin Lymphoma
cPT is an effective and well-tolerated treatment for young patients with cHL, demonstrating excellent 10-year OS and RFS, even for those treated at relapse. These findings support cPT as a treatment modality, warranting further studies to assess long-term outcomes.
Authors
- Jordan Milner (ORCID: https://orcid.org/0000-0001-5768-7745)
- Allison S. Bechtel
- Daniel J. Indelicato (ORCID: https://orcid.org/0000-0001-5765-1873)
- Nancy P. Mendenhall (ORCID: https://orcid.org/0000-0003-2893-7703)
- Jennifer Dean (ORCID: https://orcid.org/0000-0002-5029-986X)
- Raymond Mailhot
- Christopher G. Morris
- Daniela Martir-Vargas
- Manisha Bansal
Institutions
- Johns Hopkins University (US)
- University of Miami (US)
- University of Florida (US)
- Nemours Children’s Clinic (US)
- Johns Hopkins All Children's Hospital (US)
- Nemours Children's Health System (US)
- Florida College (US)
Publication Details
- Journal
- International Journal of Particle Therapy
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1016/j.ijpt.2025.101295
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00